Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Sarepta Therapeutics, Inc. - Common Stock
(NQ:
SRPT
)
21.40
+1.10 (+5.42%)
Streaming Delayed Price
Updated: 12:24 PM EDT, Aug 15, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Sarepta Therapeutics, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
30
31
Next >
Sarepta Therapeutics Crashes 26% After A Third Gene Therapy Patient Dies
July 18, 2025
The move wiped out all of the gains Sarepta lodged Thursday after announcing its restructuring plans.
Via
Investor's Business Daily
Topics
Death
Stocks
Netflix, BlackSky Technology And Other Big Stocks Moving Lower In Friday's Pre-Market Session
July 18, 2025
Via
Benzinga
Get insights into the top gainers and losers of Friday's pre-market session.
July 18, 2025
The US market is yet to commence its session on Friday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements.
Via
Chartmill
SRPT Investors Have Opportunity to Lead Sarepta Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm
July 18, 2025
From
Schall Law
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's Pre-Market Session
July 18, 2025
Via
Benzinga
Sarepta Therapeutics Stock Plunges Over 30% In Friday Pre-Market: What's Going On
July 18, 2025
Shares of Sarepta Therapeutics (NASDAQ: SRPT) plunged 26.85% in Friday pre-market after a clinical trial participant died following treatment with a gene therapy, marking the third death linked to the...
Via
Benzinga
Topics
Death
Why Interactive Brokers Group Shares Are Trading Higher By 5%; Here Are 20 Stocks Moving Premarket
July 18, 2025
Via
Benzinga
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Sarepta Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SRPT
July 17, 2025
From
The Rosen Law Firm PA
Via
GlobeNewswire
Sarepta Therapeutics' Reorganization Boosts Investor Confidence
July 17, 2025
Sarepta agrees to FDA's black box warning and announces major restructuring, including job cuts and cost-saving measures to meet 2027 goals.
Via
Benzinga
AAR, Lucid Group, Monarch Casino & Resort And Other Big Stocks Moving Higher On Thursday
July 17, 2025
Via
Benzinga
Assessing Sarepta Therapeutics: Insights From 35 Financial Analysts
July 17, 2025
Via
Benzinga
Investors in Sarepta Therapeutics, Inc. Should Contact Levi & Korsinsky Before August 25, 2025 to Discuss Your Rights - SRPT
July 17, 2025
Via
TheNewswire.com
Topics
Fraud
Lawsuit
Investors in Sarepta Therapeutics, Inc. Should Contact Levi & Korsinsky Before August 25, 2025 to Discuss Your Rights - SRPT
July 17, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Fraud
Lawsuit
What's going on in today's pre-market session
July 17, 2025
Before the opening bell on Thursday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session.
Via
Chartmill
12 Health Care Stocks Moving In Thursday's Pre-Market Session
July 17, 2025
Via
Benzinga
Why Sarepta Therapeutics Shares Are Trading Higher By 34%; Here Are 20 Stocks Moving Premarket
July 17, 2025
Via
Benzinga
Sarepta To Lay Off 500 Employees After Two Patient Deaths; Shares Catapult
July 16, 2025
The company is also restructuring with the hopes of saving $400 million in expenses.
Via
Investor's Business Daily
Topics
Death
Earnings
Government
Sarepta Surges After-Hours As It Slashes 500 Jobs Amid FDA Black Box Warning For Gene Therapy — Retail Eyes Rebound
July 16, 2025
The company also updated investors on its ELEVIDYS gene therapy label, agreed to an FDA-requested black box warning, and outlined plans to resume dosing in non-ambulant patients.
Via
Stocktwits
Topics
Death
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Hims & Hers and Sarepta and Encourages Investors to Contact the Firm
July 16, 2025
From
Bragar Eagel & Squire
Via
GlobeNewswire
12 Health Care Stocks Moving In Wednesday's After-Market Session
July 16, 2025
Via
Benzinga
Sarepta Therapeutics Stock Is Surging After The Bell: What's Going On?
July 16, 2025
Via
Benzinga
Get insights into the top gainers and losers of Wednesday's after-hours session.
July 16, 2025
The regular session of the US market on Wednesday is now over, but let's get a preview of the after-hours session and explore the top gainers and losers driving the post-market movements.
Via
Chartmill
Sarepta Therapeutics Announces Strategic Restructuring and Pipeline Prioritization Plan to Maintain Long-term, Sustainable Growth and Provides Update on ELEVIDYS Label
July 16, 2025
From
Sarepta Therapeutics, Inc.
Via
Business Wire
Sarepta Therapeutics, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - SRPT
July 16, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Fraud
Lawsuit
Sarepta Therapeutics, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - SRPT
July 16, 2025
Via
TheNewswire.com
Topics
Fraud
Lawsuit
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sarepta Therapeutics
July 16, 2025
From
Faruqi & Faruqi LLP
Via
GlobeNewswire
Contact Levi & Korsinsky by August 25, 2025 Deadline to Join Class Action Against Sarepta Therapeutics, Inc. (SRPT)
July 15, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Fraud
Lawsuit
Contact Levi & Korsinsky by August 25, 2025 Deadline to Join Class Action Against Sarepta Therapeutics, Inc. (SRPT)
July 15, 2025
Via
TheNewswire.com
Topics
Fraud
Lawsuit
ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Sarepta Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SRPT
July 14, 2025
From
The Rosen Law Firm PA
Via
GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Sarepta Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - SRPT
July 14, 2025
From
Pomerantz LLP
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
7
8
9
...
30
31
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.